Objectives
We hypothesized that treatment with dapagliflozin for two weeks may prevent vascular IRI after forearm ischemia compared to placebo.
The primary objective was to test the effect of dapagliflozin compared to placebo on…
Dapagliflozin prevents vascular ischemia-reperfusion injury in healthy young males: a randomized, placebo-controlled, double-blinded trial
